Creatine has a reputation as a gym supplement, yet the most interesting questions about it now sit above the neck. How much creatine does the brain need, and is the familiar 5 gram scoop enough to reach it? Dr. Darren Candow, a Canadian researcher who says he has published more than 120 papers on creatine and run 30 to 40 studies in his own laboratory, calls this the dosing dilemma. In a long interview he set out a simple framework: different tissues respond to different amounts, and the brain is the hardest tissue to reach.
His summary runs as follows. Muscle responds to 3 to 5 grams a day. Bone, in the studies that showed any effect, needed 8 to 12 grams a day alongside exercise. The brain, he argues, probably needs nothing extra when it is rested and healthy, but may respond to around 20 grams when it is under metabolic stress such as sleep loss. He describes his own habit of at least 10 grams a day as a safety net that covers all three.
This article checks each part of that framework against published research. The muscle evidence is strong and the safety record is reassuring. The brain evidence is more uneven than the confident tone of the interview suggests. A handful of small trials point to benefits under stress, while the European Food Safety Authority reviewed the literature in 2024 and concluded that a cause and effect relationship between creatine and better cognition has not been established. Candow himself says the brain claims are getting overhyped, and that candour is a useful guide for reading everything below.
Creatine and Brain Energy
Candow starts with energy. Every cell runs on a molecule called ATP, and hard working tissue burns through it quickly. Creatine helps rebuild ATP when demand spikes. He compares the pair to a hero and a sidekick: ATP gets the attention, while creatine steps in to keep it topped up during sprinting, lifting, or any short and intense effort.
According to Candow, the body makes about 1 to 3 grams of creatine a day in the liver and the brain, not in muscle, even though about 95 percent of the body’s creatine is stored in muscle. Other published descriptions also give the kidneys and pancreas a role in synthesis, so the two organ picture is a simplification, but the main point stands: muscle imports its creatine and the brain largely supplies its own.
Diet adds to that supply. Candow explains that creatine is found only in animal flesh, with herring, salmon, and beef among the richer sources and only tiny amounts in dairy. Reaching even 3 grams a day from food alone would take a large amount of meat. A small number of people are born unable to make creatine and need supplements for medical reasons.
The brain matters here because of its energy use. Candow notes that it consumes about 20 percent of the body’s energy at rest. That matches a widely cited paper in the Proceedings of the National Academy of Sciences, which describes the adult brain as about 2 percent of body weight using about 20 percent of the body’s oxygen and calories. Candow put the brain’s weight at about 2 kg. At 2 percent of body weight, the brain of a 70 kg adult is nearer 1.4 kg, so his number is high, though the energy point is sound.
From this he builds his central idea. A rested, healthy brain probably makes enough creatine for itself. A brain under metabolic stress is different. Sleep loss, night shifts, exam weeks, long haul travel, and sustained mental pressure all raise energy demand, and in those conditions he believes the brain starts to rely on outside creatine. He adds that people with Alzheimer’s disease, clinical depression, and concussion tend to show reduced brain creatine.
Two details follow. Candow stresses that creatine struggles to cross the blood brain barrier, which is why brain studies use higher doses or longer periods than muscle studies. He is also clear that creatine does not boost a healthy brain beyond normal. It most likely brings depleted levels back to where they were before the stress. Once stores are raised they fall slowly. Muscle takes about a month to return to baseline, and he describes the brain figure, somewhere between five weeks and three months, as speculation.
Muscle and Bone Doses
Muscle is where the evidence is strongest, and Candow’s numbers are modest. He explains that 3 to 5 grams a day is effective across the lifespan, and that 3 grams a day will saturate muscle in roughly a month. A loading phase of about 20 grams a day for five to seven days fills muscle faster, but he links it to stomach upset and temporary water retention and says most people can skip it. A 2021 expert review of common creatine questions, on which Candow is a coauthor, agrees that loading is optional.
The main benefit, he says, is training capacity. People on creatine manage more repetitions or sets, recover faster, and accumulate more training volume. He describes an eight week study in which training volume rose on creatine, fell back to placebo levels about four weeks after stopping, and rebounded when creatine was restarted, and he sees an application for people returning from injury.
On size, Candow puts the typical extra gain at about 1.2 kg of lean mass when creatine is added to weight training. A meta analysis of older adults in the Open Access Journal of Sports Medicine found a similar figure, about 1.37 kg more lean tissue than training alone, along with better chest press and leg press strength. Candow adds a caveat that often goes missing: lean mass includes water, organs, and connective tissue, and only about half of it is muscle. His conclusion is that creatine has more robust evidence for muscle performance than for muscle size.
For adults over 50 he suggests slightly more, around 7 or 8 grams a day, and he highlights functional gains such as rising from a chair. He also says his group’s meta analyses show a small drop in fat mass, an effect he describes as indirect. An earlier meta analysis of older adults in Medicine and Science in Sports and Exercise found no effect on fat mass, so this is a modest possibility at best.
Bone is where the dilemma begins. Candow states that the lowest dose shown to help bone is about 8 grams a day, with studies running up to 12 grams, and that no study has shown a bone benefit without exercise. He describes work in postmenopausal women studying whether creatine plus resistance training affects the loss of bone mineral density around the hip, alongside a larger trial that found no effect on bone mineral density. He is explicit that creatine did not increase bone density and is not a treatment for osteoporosis. He suggests creatine may energise bone building cells and quieten bone resorbing cells, and he likens this to bisphosphonate drugs. That comparison is his analogy and no trial evidence was found to support it.
The published record is more mixed than his summary. A 12 month trial from his collaborators, using about 0.1 grams per kg of body weight a day, did report preserved bone density at the femoral neck. The larger follow up, a two year randomized trial of 237 postmenopausal women taking 0.14 grams per kg a day, found no effect on bone mineral density at the femoral neck, total hip, or lumbar spine. It did find that creatine maintained two geometric measures linked to bone bending strength, and it improved walking speed, but it had no effect on bench press or squat strength. The authors suggested the earlier density result may have been a chance finding, and they noted low adherence to the supplement. Candow’s description of this trial is therefore more positive than its abstract. Creatine may help preserve some structural properties of bone during training, while an effect on bone density itself has not been confirmed.
Brain Doses Under Stress
Candow’s brain framework rests on one observation. In his reading, cognitive benefits show up mainly when the brain is stressed and the dose is high. He suggests that 10 grams a day is a reasonable everyday amount, that a couple of studies show benefits at 15 grams, and that about 20 grams is the most viable dose under acute stress.
The study he leans on most comes from a German national research centre and was published in Scientific Reports in 2024. Fifteen healthy young adults were kept awake for 21 hours on two occasions and received either a placebo or a single dose of creatine at 0.35 grams per kg of body weight. For a 70 to 85 kg person that is roughly 25 to 30 grams, which matches the 30 gram figure Candow uses. Brain scans showed shifts in energy related metabolites after creatine, and performance on cognitive tests, including processing speed, held up better than on placebo. Reports on the study describe the effect as peaking about four hours after the dose and lasting up to nine hours. The design was double blind, with each person serving as their own control, but it is a single small study. The lead researcher was also quoted advising people not to take such a large single dose at home, citing the load on the kidneys.
Candow says a later study from the same group used 0.2 grams per kg, about 14 grams for a 70 kg person, and did not have the same effect. The published paper, which appeared in Nutrients in 2026, reads more favourably. In 29 healthy adults kept awake for 21 hours, the lower dose was associated with less deterioration on logic and number tasks, language processing speed, and a vigilance test. The two doses were not compared head to head, so the lower dose may well be less potent, but the published results do not show that it failed. The interview may predate the paper.
The second study he highlights involves the Stroop test, in which people must name the ink colour of a word that spells a different colour. Candow had his interviewer try it, and the host stumbled within a few lines. In the study, published in Medicine and Science in Sports and Exercise, 14 participants took 20 grams of creatine a day for seven days, or a placebo, and then performed the Stroop task for 90 minutes. Accuracy was about 4.9 percent higher with creatine, and handgrip endurance improved. However, creatine did not prevent the decline that mental fatigue caused in a sport specific reaction task or in a second attention test. Candow describes the study as showing better speed and cognition. The measured gain was in accuracy, and the overall result was mixed.
He also tempers expectations. People taking creatine for brain reasons will most likely feel nothing. Any benefit shows up as slightly better performance on demanding tasks, not as a sensation of alertness. He mentions taking a high dose around travel, and is open that any impression of benefit is a single personal observation the research has not tested.
How does this sit with the wider evidence? A 2024 systematic review and meta analysis in Frontiers in Nutrition pooled 16 randomized trials with 492 participants. It found a small positive effect on memory, rated as moderate certainty, and improvements in attention time and processing speed rated as low certainty. It found no significant effect on overall cognitive function or executive function. Benefits looked larger in people with health conditions, in adults aged 18 to 60, and in women.
Regulators have been less persuaded. In November 2024 the European Food Safety Authority assessed a proposed health claim that daily creatine improves cognitive function. Its panel noted that an acute effect on working memory appeared in two studies at 20 grams a day for five to seven days, but not at lower doses of about 2 to 14 grams a day, and not with 5 grams a day for six weeks. It judged the evidence for a mechanism to be weak and concluded that a cause and effect relationship had not been established. The European Commission formally refused the claim in 2026. The panel’s reading of the dose pattern is close to Candow’s: where effects appear, they appear at high doses over short periods. The difference lies in how much weight those few studies can bear.
Candow adds his own caution. He says many people now take 20 or 30 grams every day on the strength of the sleep deprivation studies, and he does not recommend it. Those trials tested a single night of acute stress. Nobody knows, he points out, whether neurons swell with water at sustained high doses, or whether large daily amounts might turn down the body’s own production. His suggestion is a moderate daily amount, with a temporary increase only around an unusually demanding period.
Alzheimer’s and Depression Research
Candow describes Alzheimer’s disease as the clinical area with the most hope attached. He cites a pilot trial in which people with Alzheimer’s took 20 grams of creatine a day for eight weeks. That study, run at the University of Kansas Medical Center and published in 2025 in Alzheimer’s and Dementia: Translational Research and Clinical Interventions, enrolled 20 participants. Brain scans in that small pilot showed an average 11 percent rise in total brain creatine, and the researchers recorded changes on several cognitive measures, including working memory, though the study had no placebo group. The host attributed this work to a different journal, which appears to be an error.
Candow names the main limit himself: there was no placebo group. The study authors make the same point, warning that practice effects or expectation could explain the improvements, and coverage of the paper notes no change on a standard clinic screening test. A companion paper in Frontiers in Nutrition reported increases in handgrip strength and muscle size. The host quoted a grip strength gain of 1.9 kg, a figure that could not be confirmed from the abstract. Candow says cell and rodent studies hint at a protective effect on neurons and describes the human evidence as being in its infancy. This is a feasibility result that justifies a larger placebo controlled trial, and nothing more yet.
On mental health, Candow says the most active area of research is depression, and he is careful to say any role for creatine has only been studied alongside standard treatment, never as a replacement. The key trial appeared in the American Journal of Psychiatry in 2012. Fifty two women with major depressive disorder all received the antidepressant escitalopram and were randomly assigned to add either 5 grams of creatine a day or a placebo for eight weeks. In that trial the creatine group changed faster on the depression scale used, with a difference visible by week two, and the researchers reported a higher remission rate in the creatine arm than the placebo arm at eight weeks. That is the doubling the interview refers to. It is a small trial, and 13 women did not complete it. Candow says he is now collaborating on a trial of creatine as a standalone treatment, which has not yet reported.
The interview also cites a population study, described by the host as covering more than 200,000 adults. The study that matches was published in Translational Psychiatry in 2020 and analysed 22,692 American adults from a national nutrition survey. Depression was present in about 10.2 per 100 people in the lowest quarter of dietary creatine intake and about 6.0 per 100 in the highest quarter, and the link held after adjusting for income, activity, and other factors. The sample size quoted in the interview is about ten times too large. More importantly, a survey cannot show that low creatine causes depression. People who eat little meat or fish differ in many ways, and depression itself changes appetite and diet.
Candow mentions other areas briefly. He is curious about concussion, noting that rodents given creatine before a head injury recover faster, and he has raised creatine as a research question for people in contact sports, based on animal data he describes as a hypothesis rather than a finding. That suggestion rests on animal data and is best read as his hypothesis. He also states that 20 grams a day for five days before long endurance events lowered markers of inflammation, while stressing that creatine does not act like a painkiller. Those studies were not checked for this article. Finally, the interview opens with a passing mention of possible anti cancer properties. No detail or study was offered, and it should not be treated as an established benefit.
Safety and Common Myths
Candow was asked about five common fears, and the research mostly supports him, with a few adjustments.
The first is kidney damage, which he calls the biggest myth. Creatine breaks down into creatinine, the same waste product doctors measure to estimate kidney filtration. A person taking creatine can show slightly raised creatinine and a lower estimated filtration rate without any change in how the kidneys are working. Candow advises telling a doctor about creatine use before blood tests. A 2025 systematic review and meta analysis in BMC Nephrology supports the mechanism: creatine was associated with a small rise in blood creatinine and no significant change in filtration rate. His figure of 99 false alarms in 100 is his own estimate. He is clear that anyone with a preexisting medical condition should speak to a doctor first.
The second is water retention. Candow agrees that a loading phase can cause a few days of extra water weight. After the first week, he explains, the water sits inside muscle cells, and he believes that cell swelling is one of the signals that switches on muscle protein building.
The third is that creatine is only for men. Candow calls this completely false and says women respond well for strength, lean mass, and performance. The 2021 expert review reaches the same view.
The fourth is hair loss. The fear traces to a 2009 study of rugby players in which a loading dose raised levels of the hormone DHT. Candow points out that the hormone stayed within the normal range and that nobody measured hair. He describes DHT as a precursor of testosterone, which is the wrong way round, since the body converts testosterone into DHT. He also says a recent trial tested 5 grams a day for six to eight weeks. The trial in question, published in 2025, ran for 12 weeks. It assigned 45 resistance trained men to creatine or placebo, 38 completed it, and there were no differences in DHT, testosterone, hair density, or hair thickness. It is one modest study in a sports nutrition society journal, but it is the only trial to have measured hair directly.
The fifth is muscle cramps. Candow considers this overplayed and argues that pulling water into muscle should reduce cramping if anything. The largest safety analysis to date adds a small qualification. Reviewing 685 clinical trials with about 26,000 participants, it found side effects reported in 13.7 percent of creatine studies and 13.2 percent of placebo studies. Stomach complaints were slightly more common with creatine, 4.9 percent of studies against 4.3 percent, as were reports of muscle cramping or pain, 2.9 percent against 0.9 percent. The differences are small, but they are not zero. This appears to be the analysis Candow means when he mentions a review of more than 25,000 cases.
On long term use, the International Society of Sports Nutrition position stand states that there is no compelling evidence of harm in healthy people at up to 30 grams a day for five years. One note on independence is worth making. Much of the safety literature is written by researchers who work closely on creatine, and Candow is a coauthor of both the position stand and the 2021 review. The kidney meta analysis and the European assessment come from outside that circle.
Who May Benefit Most
Vegans and vegetarians come first. With no dietary creatine, they rely on what the body makes, and Candow says they respond better than anyone. A systematic review in the International Journal of Environmental Research and Public Health partly agrees. Supplements raised muscle creatine in vegetarians, often to levels above those of meat eaters, and improved lean mass, strength, and measures of memory. However, studies were mixed on whether vegetarians gained more than omnivores, the included studies carried a moderate to high risk of bias, and brain phosphocreatine did not change. Vegetarians are likely to benefit, while the claim that they respond best of all is stronger than the evidence.
Older adults are his second group. Candow says muscle mass falls by about 1 percent a year after 40 in inactive people and strength falls faster, and that resistance training, ideally with creatine and adequate protein, flattens that curve. He stresses that it is never too late to start.
For women around menopause, he explains that estrogen appears to be involved in the enzymes that make creatine, based largely on animal and cell research. His reasoning is that falling estrogen could make supplemental creatine more useful during and after the transition. This is a hypothesis, not a settled finding.
He also describes a sleep study from his collaborators. Twenty one healthy young women took 5 grams of creatine or placebo daily for six weeks while doing resistance training twice a week, with sleep tracked by a wearable ring. Those taking creatine slept longer on training days. Candow says the difference was about an hour. The published abstract confirms a significant increase but does not state its size, and it found no change in overall sleep quality scores. He agrees it needs replication.
On children and teenagers, Candow says current reviews suggest creatine is safe at recommended doses and that at least 1 gram a day is desirable for bone and muscle development. A 2021 review in Nutrients is more reserved. It found that studies in adolescent athletes generally report performance improvements with no adverse events, while noting that far less is known in young people than in adults. The 1 gram a day figure could not be verified, and Candow himself advises parents to speak with a medical practitioner. On pregnancy, he refers to early human research in Australia and says the jury is still out, which is a reason for caution and a conversation with a clinician.
Finally, he says dose needs vary with body size and stress, and he is frank that no researcher knows the ideal dose for any individual, particularly for the brain.
Forms, Quality and Timing
Candow is unambiguous on form: creatine monohydrate. It is identical to what the body makes once dissolved, and nearly all safety and efficacy research is based on it. He acknowledges that newer forms such as creatine hydrochloride have some evidence, but says none has been shown to be safer or more effective.
On quality, he looks for monohydrate on the label, a reputable raw material source, and third party certification such as NSF, an independent testing body that began as the National Sanitation Foundation. Certification checks that the product contains what it claims and is free of contaminants such as lead and arsenic.
That matters most for gummies. The interview refers to an online investigation in which, by Candow’s account, about 90 percent of tested gummies contained no creatine. That figure could not be verified, but independent testing confirms the problem. In 2024 the supplement manufacturer NOW tested 12 creatine gummy brands and reported that roughly half contained little or no creatine. In 2025 the supplement tracking platform SuppCo reported that four of six popular gummies failed potency testing, while all five powders it tested met their label claims. Candow named one gummy brand he considers validated. Results for individual brands have varied between testers, so no brand is named here. Plain monohydrate powder remains the most dependable format.
On how to take it, Candow has become interested in what he calls microdosing, meaning splitting the day’s creatine into smaller servings. He says this reduces stomach upset and water weight in people prone to them. He puts 5 grams in his water bottle during training and takes more in the morning.
The host described feeling dizzy or slightly sick after larger single doses. Candow offered a mechanism: creatine synthesis normally uses many of the body’s methyl groups, so a large dose might free them for making adrenaline, producing a jittery feeling, especially on an empty stomach. No direct human evidence for this was found. The practical advice, smaller doses with food and fluid, stands on its own.
On timing, Candow says it does not matter, and he mentions a newly accepted paper from his group on this point, which could not be located. He considers creatine fine to mix into coffee, yogurt, or juice, and believes caffeine intake under about 350 mg is not a problem, while acknowledging some controversy. His final point is about habit. Creatine works through accumulation, so consistency matters more than precision. Unlike caffeine, it produces no immediate sensation. At 3 to 5 grams a day, he says, people typically notice training benefits after a few weeks to a month.
Creatine in the Health Toolbox
Some of the most useful parts of the interview keep creatine in proportion. Candow uses the image of a toolbox. The hammer, the tool used most, is weight training. The screwdriver is aerobic exercise or sleep, which he ranks well ahead of any supplement. Creatine is more like an adjustable wrench: versatile, helpful for muscle, a little for bone, possibly for brain, and no substitute for the basic tools.
He argues that resistance training is the single most valuable form of exercise, because it delivers much of what cardio offers while also building muscle and strength. He says lighter weights lifted close to fatigue can build as much muscle as heavy weights, while heavy lifting remains better for maximal strength. He is equally clear that people should do both kinds of exercise, and that two whole body sessions a week is enough to benefit. World Health Organization guidance is similar: 150 to 300 minutes of moderate aerobic activity a week, or 75 to 150 minutes of vigorous activity, plus muscle strengthening on two or more days.
On protein, he thinks the topic is somewhat overhyped and that most people now eat enough. He suggests 1.2 to 1.6 grams per kg of body weight a day, roughly 84 to 112 grams for a 70 kg adult. A meta analysis in the British Journal of Sports Medicine, covering 49 trials and 1,863 participants, supports the upper end of his range: intakes above about 1.6 grams per kg a day brought no further gain in lean mass. Candow adds that a few studies show creatine and protein together produce slightly more lean mass and performance than either alone.
He closes with a caution that applies directly to this article. Creatine, he says, is being overhyped, especially for the brain. It is one tool, and it works best alongside training, protein, and sleep.
Practical Dosing Takeaways
For muscle and physical function, 3 to 5 grams of creatine monohydrate a day, combined with resistance training, is supported by strong evidence. Loading is optional.
For bone, the studies that found any benefit used about 8 to 12 grams a day with resistance training. The best trial found no effect on bone density and a possible benefit for bone geometry.
For the brain, the honest answer is that nobody knows yet, and Candow says so himself. A rested, healthy brain may not benefit at all. Under acute stress such as a night without sleep, small trials suggest that single doses of roughly 14 to 30 grams, scaled to body weight, can blunt the drop in performance for several hours. A meta analysis suggests a small benefit for memory, and European regulators concluded that the overall case is unproven. Candow’s personal approach is at least 10 grams a day, rising to 20 or 25 grams for a few days around heavy travel, and he advises against large doses every day because the long term effects on the brain are unknown.
For clinical conditions, creatine has been studied as an addition to antidepressant treatment in one small randomized trial, and was measured raising brain creatine in a small uncontrolled Alzheimer’s pilot. Neither result justifies self treatment.
For safety, expect a harmless rise in blood creatinine and tell your doctor you take creatine. Anyone with kidney disease or another medical condition, anyone who is pregnant, and parents considering creatine for a child should speak with a clinician first. For quality, choose plain creatine monohydrate with third party certification, and treat gummies with caution.